Skip to main content
. 2019 Apr 30;10:421. doi: 10.3389/fneur.2019.00421

Table 2.

Comparison of characteristics of bacterial meningitis patients with normonatremia and with mild, moderate, and severe hyponatremia.

Patient characteristic Normonatremia Mild hyponatremia Moderate hyponatremia Severe hyponatremia p-value
Age (years) 0.17 (0.04,0.42) 0.08 (0.05, 0.25) 0.08 (0.52, 0.27) 0.07 (0.05, 0.5) 0.944
Anorexia (n) 30/59 (50.8%) 36/77 (46.8%) 18/26 (69.2%) 9/13 (69.2%) 0.142
Vomiting (n) 15/59 (25.4%) 15/77 (19.5%) 9/26 (34.6%) 3/13 (23.1%) 0.462
Fever (n) 56/59 (94.9%) 76/77 (98.7%) 26/26 (100%) 12/13 (92.3%) 0.225
Convulsions (n) 6/59 (10.2%) 14/77 (18.2%) 8/26 (30.8%) 9/13 (69.2%) 0.000
Impaired consciousness (GCS < 14, n) 24/59 (40.7%) 40/77 (51.9%) 22/26 (84.6%) 12/13 (92.3%) 0.000
GCS minimum score 15 (14, 15) 14 (14, 15) 14 (13, 14) 11 (8.5, 13.5) 0.000
PCPC maximum score 1 (1, 2) 2 (1, 2) 2 (2, 2) 3 (2, 4) 0.000
Duration of symptoms prior to admission (days) 3 (2, 4) 2 (1, 3) 2 (1, 4) 2 (1, 3) 0.004
3 (2, 4) 2 (1, 3) 0.000
Duration of symptom after admission (days) 1.5 (0.5–2.5) 2 (1, 4) 2.75 (1, 5) 5 (3, 5.5) 0.000
1.5 (0.5–2.5) 2.5 (1, 5) 0.000
Hospital stay (days) 20 (16, 23) 21.5 (18, 36) 21 (15.5, 41.5) 26 (20, 51) 0.044
LABORATORY TESTS
Potassium (mmol/L) 4.85 ± 0.63 4.72 ± 0.59 4.44 ± 0.51 4.19 ± 0.55 0.001
Creatinine (μmol/L) 24.8 (20.6,28.9) 23.9 (21.33,28.15) 28 (22.95,32) 27.25 (22.15,42.53) 0.158
Blood urea nitrogen (mmol/L) 3.16 (2.32, 4.04) 3.56 (2.85, 4.49) 3.08 (2.66, 4.76) 2.62 (2.08, 5.40) 0.125
Urea/creatine ratio 0.12 (0.09, 0.17) 0.14 (0.11, 0.18) 0.13 (0.09, 0.17) 0.11 (0.07, 0.15) 0.088
Uric acid (μmol/L) 182 (134.25, 254) 171 (133,217) 211 (184.75, 224) 128 (79, 189.75) 0.163
Glucose (mmol/L) 5.44 (4.72, 6.33) 5.8 (5.15, 6.91) 6.5 (5.55, 8.25) 7.45 (5.99, 11.83) 0.020
Elevated transaminases (n) 8/59 (13.6%) 11/77 (14.3%) 5/26 (19.2%) 5/13 (38.5%) 0.169
Indexes of CSF
 White cell count (/109l) 164 (68, 660) 550 (170, 1325) 360 (63.75, 4910) 540 (62.5, 3050) 0.068
  Protein (g/L)
    >3 6 (10.2%) 10 (13%) 10 (41.7%) 6 (46.2%) 0.000
    <3 53 (89.8%) 67 (87%) 14 (58.3%) 7 (53.8%)
    Median (SD) protein (<3) 0.89 (0.54, 1.6) 1.01 (0.6, 1.84) 0.71 (0.55,0.88) 0.92 (0.66,1.52) 0.221
CLINICAL COMPLICATIONS
Shock (n) 1/59 (1.7%) 1/77 (1.3%) 3/26 (11.5%) 3/13 (23.1%) 0.002
MODS (n) 1/59 (1.7%) 0/77 (0.0%) 0/26 (0.0%) 2/13 (15.4%) 0.016
Respiratory failure requiring mechanical ventilation (n) 1/59 (1.7%) 2/77 (2.6%) 0/26 (0%) 3/13 (23.1%) 0.013
Hydrocephalus (n) 4/58 (6.9%) 3/76 (%) 0/25 (0%) 0/12 (0%) 0.630
Subdural fluid accumulation (n) 7/58 (12.1%) 10/76 (13.2%) 1/25 (4%) 2/12 (16.7%) 0.580
Subdural empyema (n) 1/58 (1.7%) 2/76 (2.6%) 0/25 (0%) 1/12 (8.3%) 0.465
Brain parenchymal abnormalities (n) 5/58 (8.6%) 9/76 (11.8%) 2/25 (8%) 1/12 (8.3%) 0.912
OUTCOMES
PCPC score on discharge 1 (1,1) 1 (1,1) 1 (1,1) 1 (1,2) 0.001
Poor outcome (PCPC ≥ 2) 1/59 (1.7%) 2/77 (2.6%) 0/26 (0%) 3/13 (23.1%) 0.013

#Serum potassium levels were measured in 168 patients, creatinine and urea nitrogen in 168 patients, glucose in 89 patients, uric acid in 119 patients, and CSF protein in 173 patients.